Posterior ocular involvement in Behcet's disease and thrombophilic mutations

被引:1
|
作者
Vaya, Amparo [1 ]
Miguel De la Fuente, Jose [1 ]
Suescun, Marta [1 ]
Espana, Enrique [2 ]
Ricart, Jose M. [3 ]
机构
[1] La Fe Univ Hosp, Serv Clin Pathol, Hematol & Hemostasis Unit, Valencia 46009, Spain
[2] La Fe Univ Hosp, Ophtalmol Serv, Valencia 46009, Spain
[3] La Fe Univ Hosp, Dermatol Serv, Valencia 46009, Spain
关键词
Behcet's disease; posterior ocular involvement; factor V Leiden; prothrombin G20210A mutation; C677T MTHFR mutation; FACTOR-V-LEIDEN; PROTEIN-C RESISTANCE; RISK-FACTORS; PROTHROMBIN; REDUCTASE; ASSOCIATION;
D O I
10.3233/CH-2012-1548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is not well established whether there is an association among common inherited gene defects, Factor V (FV) Leiden, the prothrombin (PT) G20210A mutation, C677T methylene tetrahydrofolate reductase (MTHFR) and ocular Behcet's disease (BD). We aimed to evaluate the association of these mutations with posterior ocular involvement in 89 BD patients from eastern Spain (48 men and 41 women) of whom 23 had posterior ocular involvement and 66 did not. None of the 23 BD patients with posterior ocular involvement was a carrier of either FV Leiden or the PTG20210A mutation. Only 1 patient was a carrier of the 677TT MTHFR mutation, whereas 4 patients carried FV Leiden, 3 the PTG20210A mutation and 10 the 677TT MTHFR mutation in the group without posterior ocular involvement (p = 0.227, p = 0.556, p = 0.144), respectively. In our geographical area, the commonest thrombophilic mutations do not seem to be related with posterior ocular involvement in BD patients.
引用
收藏
页码:225 / 228
页数:4
相关论文
共 50 条
  • [21] Thrombophilic factors are not the leading cause of thrombosis in Behcet's disease
    Leiba, M
    Seligsohn, U
    Sidi, Y
    Harats, D
    Sela, BA
    Griffin, JH
    Livneh, A
    Rosenberg, N
    Gelernter, I
    Gur, H
    Ehrenfeld, M
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) : 1445 - 1449
  • [22] Severe primary ocular surface involvement in behcet disease
    1600, Lippincott Williams and Wilkins (91):
  • [23] Severe Primary Ocular Surface Involvement in Behcet Disease
    Zeng, Jun
    Chen, Baihua
    OPTOMETRY AND VISION SCIENCE, 2014, 91 (12) : E301 - E304
  • [24] THROMBOPHILIC FACTORS IN BEHCET'S DISEASE AND ASSOCIATION WITH CLINIC MANIFESTATIONS
    Akdemir, Serpil
    Sari, Refik Ali
    Kiziltunc, Ahmet
    Gundogdu, Mehmet
    Kiki, Ilhami
    EURASIAN JOURNAL OF MEDICINE, 2006, 38 (02): : 49 - 56
  • [25] Ocular manifestations of Behcet's disease
    Saadouli, D.
    Lahmar, A.
    Ben Mansour, K.
    El Afrit, N.
    Yahyaoui, S.
    El Afrit, M. A.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (02): : 196 - 202
  • [26] Update on ocular Behcet's disease
    Atmaca-Sonmez, Pelin
    Atmaca, Leyla S.
    Aydintug, Olcay Tiryaki
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (06) : 957 - 979
  • [27] Ocular immunopathology of Behcet's disease
    George, RK
    Chan, CC
    Whitcup, SM
    Nussenblatt, RB
    SURVEY OF OPHTHALMOLOGY, 1997, 42 (02) : 157 - 162
  • [28] Ocular manifestations of Behcet's disease
    Ebenezer, AS
    Moses, PD
    George, R
    INDIAN PEDIATRICS, 2005, 42 (09) : 942 - 945
  • [29] Ocular manifestations in Behcet's disease
    Desbois, A-C
    Terrada, C.
    Cacoub, P.
    LeHoang, P.
    Saadoun, D.
    Bodaghi, B.
    REVUE DE MEDECINE INTERNE, 2018, 39 : A31 - A36
  • [30] Interferon α for ocular Behcet's disease
    Pivetti-Pezzi, P
    Accorinti, M
    Pirraglia, MP
    Priori, R
    Valesini, G
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 1997, 75 (06): : 720 - 722